GSK set­tles key Zan­tac case ahead of tri­al

GSK has set­tled a key Zan­tac case in Cal­i­for­nia state court, the com­pa­ny an­nounced Fri­day.

The case, filed by James Goetz who al­leged the pop­u­lar heart­burn med­ica­tion caused his blad­der can­cer, would have been the first Zan­tac case to go to tri­al and was sched­uled to be­gin next month. GSK said in a state­ment Fri­day that it reached a con­fi­den­tial set­tle­ment with Goetz, dis­miss­ing the case with­out ad­mit­ting any li­a­bil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER